Fabiola Garcia Andrade

Mrs. Fabiola Garcia Andrade


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
FAFabiola Garcia Andrade
Fabiola Garcia Andrade
RVRosa María Vigueras
Rosa María Vigueras
MCMargarita Dolores Chávez-Saldaña
Margarita Dolores Chávez-Saldaña
JRJulio César Rojas-Castañeda
Julio César Rojas-Castañeda
IBIvan Uriel Bahena-Ocampo
Ivan Uriel Bahena-Ocampo
Daniel Adrian Landero HuertaDaniel Adrian Landero Huerta
Daniel Adrian Landero Huerta
Cryptorchidism (CO) is a risk factor for the development of testicular germ-cell tumors (TGCT). This is supported by reports showing the persistence of gonocytes in CO patients. These cells are proposed to be related to the development of germ-cell neoplasia in situ (GCNIS), which is considered the precursor stage/lesion of TGCT. Therefore, it is proposed that some patients with CO could express some molecular markers related to TGCT. In this study, we analyzed testicular tissue samples from CO, TGCT, and controls. We determined the expression of POU5F1, PLAP, and KIT by immunohistochemistry and that of the hsa-miR-371-373 cluster, hsa-miR-367, and LATS2, PTEN, and IGFR1 genes by RT-qPCR. We then carried out a bioinformatic analysis to identify other possible candidate genes as tumor biomarkers. We found that 16.7% (2/12) of the CO patients presented increased expression of POU5F1, KIT, PLAP, hsa-miR-371-373, and hsa-miR-367 and decreased expression of LATS2 and IGF1R. Finally, the genes ARID4B, GALNT3, and KPNA6 were identified as other possible candidate tumor biomarkers. This is the first report describing the expression of the hsa-miR-371-373 cluster, hsa-miR-367, LATS2, and IGF1R in the testicular tissues of two CO patients with cells immune-positive to POU5F1, PLAP, and KIT, which is similar to what is observed in TGCT.

Verified
Journal Article
Open access
PDF file
FAFabiola Garcia Andrade
Fabiola Garcia Andrade
RVRosa María Vigueras
Rosa María Vigueras
MCMargarita Dolores Chávez-Saldaña
Margarita Dolores Chávez-Saldaña
JRJulio César Rojas-Castañeda
Julio César Rojas-Castañeda
IBIvan Uriel Bahena-Ocampo
Ivan Uriel Bahena-Ocampo
Daniel Adrian Landero HuertaDaniel Adrian Landero Huerta
Daniel Adrian Landero Huerta
Some pediatric patients with cryptorchidism preserve cells with gonocyte characteristics beyond their differentiation period, which could support the theory of the gonocyte as a target for malignancy in the development of testicular neoplasia. One of the key molecules in gonocyte malignancy is represented by microRNAs (miRNAs). The goal of this review is to give an overview of miRNAs, a class of small non-coding RNAs that participate in the regulation of gene expression. We also aim to review the crucial role of several miRNAs that have been further described in the regulation of gonocyte differentiation to spermatogonia, which, when transformed, could give rise to germ cell neoplasia in situ, a precursor lesion to testicular germ cell tumors. Finally, the potential use of miRNAs as diagnostic and prognostic biomarkers in testicular neoplasia is addressed, due to their specificity and sensitivity compared to conventional markers, as well as their applications in therapeutics.

26 November 2025
Verified
Thesis
Open access
PDF file
FAFabiola Garcia Andrade
Fabiola Garcia Andrade
Background. Cryptorchidism (CO), or undescended testis, is the most common genitourinary malformation in newborn males and represents an important risk factor for the development of testicular germ...